Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study.
Saved in:
| Title: | Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study. |
|---|---|
| Authors: | Brewer, Molly1 (AUTHOR) mbrewer@uchc.edu, Angioli, Roberto2 (AUTHOR), Scambia, Giovani3 (AUTHOR), Lorusso, Domenica3,4 (AUTHOR), Terranova, Corrado2 (AUTHOR), Panici, Pierluigi Benedetti5 (AUTHOR), Raspagliesi, Francesco4 (AUTHOR), Scollo, Paolo6 (AUTHOR), Plotti, Francessco2 (AUTHOR), Ferrandina, Gabriella3 (AUTHOR), Salutari, Vanda3 (AUTHOR), Ricci, Caterina3 (AUTHOR), Braly, Patricia7 (AUTHOR), Holloway, Robert8 (AUTHOR), Method, Michael9 (AUTHOR), Madiyalakan, Madi10 (AUTHOR), Bayever, Eliel10 (AUTHOR), Nicodemus, Christopher11 (AUTHOR) |
| Source: | Gynecologic Oncology. Mar2020, Vol. 156 Issue 3, p523-529. 7p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
